Podcasts about Clinical

If you've ever asked yourself, “Where should I treat first,” this is the episode for you.This episode of the Unreal Results podcast, is all about one of my favorite tools that's simple to implement and wildly effective at uncovering what's actually driving pain: inhibition tests.You've probably heard me reference inhibition tests in past episodes and today I'm breaking them down into what they are, how they work, and why they can be a game-changer in identifying hidden drivers of pain, mobility limitations, and strength loss.  You'll hear me talk about what makes a good inhibition test, why so many people get it wrong, and how this approach can take you from guessing to knowing exactly where to start treatment.Whether you'rve been using the LTAP™ for some time or just starting to question traditional orthopedic thinking, this episode will show you how to listen to the body in a whole new way and get those jaw-dropping “holy cow!” moments in your sessions.Resources Mentioned In This Episode2025 Birthday Sale! Get the savings HEREEpisode 6: The Mysterious, Misunderstood, and Mistreated SI JointEpisode 9: Left Sided Sciatica or Right Sided Shoulder Pain?Episode 16: Why The Shoulder Comes LastEpisode 54: A Better Way To Assess The SI JointEpisode 77: The Controversy of the Gillet SI Joint TestGet the book Visceral Manipulation II by Jean-Pierre BarralLearn the LTAP™ In-Person in one of my upcoming coursesThe annual birthday sale is here! From July 29th-August 1st you can save up to 60% on self-paced online education courses and the Regen library.Get the birthday sale savings HERE=================================================Watch the podcast on YouTube and subscribe!Join the MovementREV email list to stay up to date on the Unreal Results Podcast and MovementREV education. Be social and follow me:Instagram | Facebook | Twitter | YouTube

AEM Podcast host Ken Milne, MD, and guest skeptic Kirsty Challen, PhD, interview lead author Hashim Kareemi, MD. Learn more in the accompanying article available in The Skeptics' Guide to Emergency Medicine.

Jaryd Bourke is a podiatrist and PhD candidate at Monash University Physiotherapy.  In this episode, Jaryd discusses Achilles tendinopathy and his research investigating heel lifts and changes in patient outcomes and biomechanics. Edit: Sorry for saying Wodonga is a city in NSW! At least I know people are listening...  it's on the border... Thanks to Jaryd for a great conversation. Use the timestamps below to jump to relevant sections. In this episode: 0:00 About this episode and welcome Jaryd 2:20 What is tendinopathy? 3:30 What is Achilles tendinopathy? 5:30 Heel lifts for Achilles tendinopathy - research 7:18 How could heel lifts help with Achilles tendinopathy symptoms 10:00 Jaryd's trial on heel lifts for Achilles tendinopathy – key methods 17:00 Clinical implications 23:33 Final thoughts Diagnostic domains, differential diagnosis and conditions requiring further medical attention that are considered important in the assessment for Achilles tendinopathy: a Delphi consensus study, link to paper:  https://bjsm.bmj.com/content/59/13/891.abstract Follow Jaryd on LinkedIn: https://www.linkedin.com/in/jaryd-bourke-86932b200/?originalSubdomain=au If you are finding this content helpful, we would appreciate a review and rating for the Physio Foundations podcast. This really helps promote the podcast to others. Hit the follow button and give us a review and 5-star rating. Stay connected: Read more at Perraton.Physio or the Perraton Physio LinkedIn page. Watch us on YouTube: https://www.youtube.com/@PerratonPhysio Follow @PerratonPhysio on Facebook, X (Twitter), Instagram and Linked In. This discussion is intended for health professionals and health professional students. Always seek guidance from a qualified health professional regarding any questions about your health or medical condition.

Clinical researchers are set to launch immune-cell therapy clinical trials aimed at tackling treatment resistance in solid tumour, supported by a €11.9 million grant from the Disruptive Technologies Innovation Fund. The project is being spearheaded by a consortium from LIfT BiSciences, University of Galway, Galway University Hospitals and Hooke Bio. The funding award, announced by Minister for Enterprise, Trade and Employment, Peter Burke T.D., and Minister for Further and Higher Education, Research, Innovation and Science, James Lawless T.D., is the largest single grant awarded by the Disruptive Technologies Innovation Fund to date, with €5.9 million in direct funding going to University of Galway. The consortium will launch the first-in-human clinical trials of a ground-breaking neutrophil-based cancer immune-cell therapy developed by LIfT BioSciences, a client of Údarás na Gaeltachta with an Irish base in An Spidéal, Co. Galway. Neutrophils are part of the first line of defence in the body's immune response. The trial will focus on patients with metastatic cervical and head and neck cancer who have exhausted all standard treatments, including checkpoint inhibitors. Trials, which will be conducted at Galway University Hospitals, are expected to begin in 2026. The grant will support the clinical development of LIfT BioSciences' next-generation cell therapy designed to overcome resistance in solid tumours, known as Immuno-Modulatory Alpha Neutrophils (IMANs). University of Galway will contribute its deep expertise in oncology and cell therapy clinical trials, as well as in translating laboratory research into clinical applications, including predictive biomarkers. Hooke Bio will provide advanced analytical tools to optimise and assess how patients respond to this novel therapy. The study will first establish the safe and effective dose of immune-cell cancer therapy and then combine this treatment with other immune-based therapies to overcome resistance to these cancer treatments observed in some patients. Professor Sean Hynes, Consultant Histopathologist and Translational Cancer Researcher from University of Galway's School of Medicine and Lead Academic of the award said: "In partnership with LiFT BioSciences and Hooke Bio, we are very excited about University of Galway and Galway University Hospital being at the forefront of delivering on new oncological cellular therapies by using neutrophils, the body's own first responders, in the fight against cancer and ensuring patients in the West of Ireland have access to such cutting edge treatments." Professor Fidelma Dunne, Director of the Institute for Clinical Trials at University of Galway, said: "The Institute for Clinical Trials is proud to support this collaboration and look forward to working closely with Disruptive Technologies Innovation Fund partners LifT BioSciences and Hooke Bio, and with academic and clinical colleagues at the University and Galway University Hospital. The programme will bring a new therapy to patients with an unmet critical need. This will be a truly inspirational journey from basic science to a first in human trial as we deliver this novel cell therapy to cancer patients." Dr Michael McCarthy, Consultant Medical Oncologist and Principal Investigator at University Hospital Galway, added: "Cancer remains one of the most complex and dynamic diseases. IMANs have the potential to overcome key limitations of current cancer treatments by activating both the innate and adaptive branches of the immune system. This dual stimulation enables a comprehensive anti-tumour response, representing a transformative advancement in cancer therapy. We are pleased to receive this grant in collaboration with LIfT and Hooke Bio, and we look forward to accelerating the clinical development of this groundbreaking immunotherapy." Dr Andrew Finnerty Manager of the Centre for Cell Manufacturing Ireland at University of Galway, said: "We at the Centre for Cell Manufacturing Ire...

Kevin and Zach are joined by star hygienist Maryann McFarland. They kick things off with a competitive discussion about their favorite games, from Maryann's professional-level Scrabble skills to Zach's past as a ranked online poker player. The conversation then shifts to the clinical topic of the day: how Maryann champions the Invisalign workflow in the practice. She provides a masterclass on her process, detailing every step from initial patient contact and leveraging in-office marketing to using photos on a big-screen monitor, discussing financials, and performing the digital scan—all while emphasizing the crucial role of teamwork and efficiency. Key Takeaways: Empower the Hygiene Team: A trained and motivated hygienist can be the primary driver for Invisalign cases, from the initial conversation to the digital scan, freeing up the doctor's time and boosting production. A System Creates Efficiency: The practice utilizes a highly systematic, team-based approach. While one person engages the patient, others prepare financial plans or manages imaging in the background, eliminating bottlenecks and making the process fit within a standard appointment. Visuals Drive Acceptance: Using large, high-quality photos on a monitor is a powerful tool. Showing patients their own crowding, wear, or abfractions and then asking, "Are you happy with your smile?" is more effective than just describing the problem. Make it Easy to Say Yes: Streamline the financial conversation by having payment options prepared in advance. Presenting clear solutions immediately after the patient expresses interest removes a major barrier to starting treatment. Create Urgency (and Follow Up): Offering to scan an interested patient on the spot capitalizes on their motivation. For those who need to think about it, sending them home with a signed financial plan and following up creates a clear path to starting their case. Join the Very Dental Facebook group using the password "Timmerman," Hornbrook" or "McWethy," "Papa Randy," "Lipscomb" or "Gary!" The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! -- Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code “VERYDENTAL10” you'll get another 10% off your order! Go save yourself some money and support the show all at the same time! -- The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! -- Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! -- CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

Counting out pills in fives, working with million-dollar drugs, and ensuring the right medication in the right dose gets delivered at the right moment with Rose Davin, a pharmacy technician in Rochester, New York. What are the layers of protection that prevent pharmacy employees from absconding with opioids? And what happens if a technician accidentally drops a pill on the floor?IF YOU LIKE THIS EPISODE: Check out what it's like to be a nurse, a veterinarian, or a hospice nurse.WANT MORE EPISODE SUGGESTIONS? Grab our What It's Like To Be... "starter pack". It's a curated Spotify playlist with some essential episodes from our back catalogue. GOT A COMMENT OR SUGGESTION? Email us at jobs@whatitslike.com FOR SPONSORSHIP OPPORTUNITIES: Email us at partnerships@whatitslike.com WANT TO BE ON THE SHOW? Leave us a voicemail at (919) 213-0456. We'll ask you to answer two questions: 1. What's a word or phrase that only someone from your profession would be likely to know and what does it mean? 2. What's a specific story you tell your friends that happened on the job? It could be funny, sad, anxiety-making, pride-inducing or otherwise. We can't respond to every message, but we do listen to all of them! We'll follow up if it's a good fit.

Featuring an interview with Dr Hope S Rugo, including the following topics: Pharmacologic features of antibody-drug conjugates (ADCs) and implications for their efficacy and toxicity in HR-positive breast cancer (0:00) Clinical and biological factors influencing the sequencing of approved ADCs for HR-positive and triple-negative metastatic breast cancer (4:03) Management of common toxicities with approved ADCs (10:48) Sacituzumab govitecan as first-line therapy for metastatic triple-negative breast cancer (18:17) Trastuzumab deruxtecan in combination with pertuzumab as first-line therapy for HER2-positive metastatic breast cancer (21:09) CME information and select publications

A revolution in pain management has arrived. The FDA's approval of Suzetrigine in January 2025 introduces the first non-opioid analgesic for moderate to severe pain in over twenty years. This breakthrough medication targets the voltage-gated sodium channel, NAV1.8, effectively blocking pain signals at their source before they reach the brain.What makes Suzetrigine remarkable is its precision. With over 30,000-fold selectivity for NAV1.8 channels, it delivers powerful analgesia without affecting the brain or heart, eliminating addiction risk, and minimizing side effects. Clinical trials involving over 2,100 patients demonstrated pain relief comparable to opioid-acetaminophen combinations but with a safety profile similar to placebo. For the more than 50% of surgical patients who experience moderate to severe postoperative pain, this non-addictive alternative represents a genuine breakthrough. Looking ahead, an exciting pipeline of additional NAV1.8 channel blockers, including intravenous formulations, promises to further transform perioperative pain management.Have you struggled with limited options for managing your patients' postoperative pain? Subscribe to the Anesthesia Patient Safety Podcast for more on groundbreaking developments like Suzetrigine that are changing how we approach patient care and safety. Leave us a review to share your thoughts on this revolutionary advance in pain management.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/265-the-breakthrough-drug-changing-perioperative-pain-management/© 2025, The Anesthesia Patient Safety Foundation

If you would like to buy lifetime access to the 31 sessions from the 2025 Neurodiverse Love Conference click here and use code Podcast50 to get $50 off the conference price.Also, to learn more about the other resources Mona has available you can check out her website.____________________________________________________________During this session from the 2025 Neurodiverse Love Conference Michelle Garnett and Tony Attwood share ways in which couples can embrace neurodiversity in their relationship.  More specifically they will address: understanding neurodiversity, enhancing communication, celebrating strengths, and creating coping strategies together.With a remarkable career spanning five decades, Professor Tony Attwood is one of the world's foremost specialists on Autism. He holds an Honor's degree in Psychology from the University of Hull, a Master's degree in clinical psychology from the University of Surrey, and a PhD from the University of London. Currently serving as an adjunct Professor at Griffith University in Queensland, Tony's impact has enriched the global understanding of autism.Alongside Dr. Michelle Garnett, Tony co-founded Attwood & Garnett Events in 2019, driven by the shared goal of enhancing autism awareness and understanding. Their shared vision seeks to reshape the narrative surrounding autism to create a world where autism is embraced, and the diverse strengths, talents, and perspectives of autistic individuals are celebrated. This transformative narrative fosters a more inclusive and accepting society, benefitting all its members.  Renowned for his extensive contributions to understanding Asperger's Syndrome, now commonly referred to as autism, Tony has authored numerous publications on the subject. His seminal book, Asperger's Syndrome: A Guide for Parents and Professionals debuted in 1998, resonated globally and has since found its voice in over 25 languages, making his insights accessible across cultures and continents.  With a dedicated commitment to practical application, he has run a private practice for 30 years, only recently closing his books due to a long waiting list. Beyond his clinical work, he dedicates significant time to travel, sharing insights and knowledge through workshops and seminars across national and international platforms.Dr. Michelle Garnett is a clinical psychologist with more than 30 years specializing in autism. In 2005, she founded Minds & Hearts, a clinic specializing in autism, where she served as Clinical & Managing Director for 14 years until 2019. Alongside Tony Attwood she co-founded Attwood & Garnett Events in 2019.In addition to her extensive private practice, Michelle has significantly contributed to autism research, authored influential books, and engaged in impactful speaking engagements. Her peer-reviewed research has informed our understanding of early autism identification, the female autism profile, and the link between mental health and positive outcomes in autistic individuals. She has co-authored six respected books on autism, including the influential Spectrum Women: Walking to the Beat of Autism (2018) with Barb Cook, a seminal work on the female autism experience. Her recent books, Having Fun with Feelings on the Autism Spectrum and Ten Steps to Reducing Your Child's Anxiety on the Autism Spectrum offer invaluable guidance to parents of young autistic children.Michelle is a sought-after presence in academic circles, presenting as a keynote speaker at conferences and conducting workshops, seminars, and training sessions on autism across Australia, the UK, and Europe. Her influence extends to universities, autism organizations, government, and non-governmental bodies, solidifying her reputation as a prominent figure in the autism field. Michelle is autistic and has ADHD, late diagnosed. To learn more about the workshops and other resources Michelle and Tony have available you can check out their website https://attwoodandgarnettevents.com/

Grab your FREE checklist now to learn how to thrive in today's competitive Pilates business landscape: David's Competitive Edge Checklist What if your Google Reviews could do the selling for you? In this episode, David Gunther and Craig Maginness unpack how real client stories, culture alignment, and strategic authenticity can outmatch big-budget franchise marketing. In this conversation, David and Craig dive deep into the power of five-star Google Reviews. Not just for credibility, but for creating deep alignment between your studio culture and your ideal clients. You'll discover how using real stories from happy clients can sharpen your value proposition, elevate team culture, and repel the wrong-fit clients.  

Contributor: Taylor Lynch, MD Educational Pearls: Dilutional Hyponatremia: Occurs when there is an excess of free water relative to sodium in the body. Causes a falsely low sodium concentration without a true change in total body sodium. Commonly seen in DKA: Hyperglycemia raises plasma osmolality. Water shifts from the intracellular to extracellular space. This dilutes serum sodium, creating apparent hyponatremia. Corrected sodium calculation: Use tools like MDCALC, or apply this formula: Add 1.6 mEq/L to the measured sodium for every 100 mg/dL increase in glucose above 100. Clinical relevance: Considering corrected sodium in DKA is crucial, as the lab value may not be reflective of actual sodium depletion. True severe hyponatremia can lead to complications like seizures May require treatment with hypertonic saline. References: Fulop M. Acid–base problems in diabetic ketoacidosis. Am J Med Sci. 2008;336(4):274-276. doi:10.1097/MAJ.0b013e318180f478 Palmer BF, Clegg DJ. Electrolyte and Acid–Base Disturbances in Patients with Diabetes Mellitus. N Engl J Med. 2015;373(6):548-559. doi:10.1056/NEJMra1503102 Spasovski G, Vanholder R, Allolio B, et al. Diagnosis and management of hyponatremia: a review. JAMA. 2014;312(24):2640–2650. doi:10.1001/jama.2014.13773 Summarized by Ashley Lyons, OMS3 | Edited by Ashley Lyons & Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/  

PelviCon Speaker Series: Fiona Rogers on Chronic Pelvic Pain, Modalities & 40+ Years in the FieldWe're kicking off our PelviCon Speaker Interview Series with none other than Fiona Rogers—a legend in the field of pelvic health!With more than 40 years of experience as a physiotherapist, Fiona has spoken all over the world and helped shape how we treat pelvic pain today. In this episode, we dive into:

Are you a clinician looking to improve your practice? Dr. Megan DeLeon, a Board Certified Behavior Analyst and the founder of the Do Better Movement, a professional development initiative for behavior analysts aimed at developing humane, culturally-informed, and compassionate interventions, talks about how behavior analysts can do better in the areas of early intervention and addressing challenging behaviors. Welcome to Autism Tips & Tools, where we highlight the best practical guidance from previous episodes of Autism Knows No Borders. Whether you're a self-advocate, a family member, or a service provider, there's something here for you! This conversation with Dr. Megan DeLeon was originally released on July 22, 2021. Would you like to hear Megan talk about how to improve collaboration with parents or other professionals and provide services with compassion? Click the link below for the full conversation and be sure to subscribe to hear more from people connected to autism inspiring change and building community.  The Do Better Movement, with Dr. Megan DeLeon | TBT Let's work together to transform how the world relates to autism. ----more---- We appreciate your time. If you enjoy this podcast and you'd like to support our mission, please take just a few seconds to share it with one person who you think will find value in it too. Follow us on Instagram: @autismpodcast Join our community on Mighty Networks: Global Autism Community Subscribe to our YouTube channel: Global Autism Project We would love to hear your feedback about the show. Please fill out this short survey to let us know your thoughts: Listener Survey

Dr. Steven Gundry is a renowned cardiothoracic surgeon, medical researcher, and bestselling author known for his pioneering work on nutrition, gut health, and chronic disease. After decades as a leading heart surgeon, he shifted his focus to preventative medicine, founding the Gundry MD clinic to help patients heal through science-backed dietary interventions. He is the author of several bestselling books, including The Plant Paradox and his latest release, The Gut Brain Paradox, which explores the powerful connection between the microbiome and mental health. Dr. Gundry continues to challenge conventional wisdom with his cutting-edge insights into personalized nutrition and longevity.In our conversation we discuss:(00:32) – What are lectins and how they work(03:26) – Foods high in lectins in daily diets(04:48) – Do cooking methods reduce lectin effects?(10:22) – Is glyphosate weakening gut defenses?(10:26) – Are lectins studied in human trials?(12:06) – Clinical findings from autoimmune patients(16:55) – Could glyphosate be the real issue?(17:15) – Do blue zone diets include lectins?(22:09) – Why goat and sheep products help longevity(25:17) – Should healthy people avoid lectins too?(31:05) – Low-toxin vegetables and how to prepare them(37:23) – Should we avoid fruit or just fructose?(43:06) – Best fruits to eat and avoid(48:10) – When is the best time to eat fruit?(53:29) – Are superagers born with better microbiomes?(55:47) – How Gundry's views evolved over timeLearn more about Dr. Steven GundryWebsite – https://drgundry.com/New book – https://www.amazon.com/Gut-Brain-Paradox-Improve-Reverse-Microbiome/dp/0062911805Watch full episodes on: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@seankim⁠⁠⁠⁠⁠⁠⁠Connect on IG: ⁠⁠⁠⁠⁠⁠https://instagram.com/heyseankim

What if AI could help schools not just support educators as they work to manage student mental health needs, but prevent crises before they start? In this thought-provoking episode, Dr. Elsa Friis, licensed clinical psychologist from Alongside, returns to discuss how her team is using clinician-built AI tools to support students, educators, and families. From building trust through anonymity to boosting classroom attendance, Elsa shares research, real stories, and the myths she's constantly debunking.

Roy earned his B.S. and M.S. in Clinical and Counseling Psychology from Abilene Christian University. He has served as a pastor, ministry executive, coach and counselor for nonprofits and churches. His body of work in Christian relationships was recognized with an Honorary Doctorate from Grace Global Seminary in 2017.https://thecrucibleproject.org/https://thecrucibleproject.org/crucible-weekend-for-men/BACKGROUND FAITH JOURNEYSAFE LANDING ZONE:  RESUME/ CAREER PATHMASTERS IN PSYCHOLOGY EXECUTIVE DIRECTOR CRUCIBLE 2019REGIONAL LEADER OF HOUSTON CRUCIBLE COMMUNITYHOW IS GOD SHAPING OR RE-SHAPING YOU THIS SEASON OF LIFE?PERSONAL BAGGAGE OR WOUNDS YOU'VE OVERCOME:  AS IT RELATES TO YOUR WORK WITH THE CRUCIBLE PROJECTBOOK: UNSTUCK:  7 STEPS TO BREAK FREE AND LIVE COURAGEOUSLY WHY WRITE THIS BOOK?WHO IS IT FOR?COMMON BONDAGE OR WOUND AMONG MEN?WHAT DOES LIVE COURAGEOUSLY LOOK LIKE?WHAT DOES IT REQUIRE?IDENTITYWHO AND WHOSEWHAT DEFINES YOU?HOW DO MOMENTS MIS-DEFINE US?TAKE RESPONSIBILITY WHY WE AVOID ?WHY EASILY OVERWHELMED ?GET CLEAR ON WHAT YOU WANTLEARN HOW TO DREAM AGAINSTART WHERE YOU AREREGRET IS THE ROADBLOCK TO DREAMING?BREAK FREE FROM SHAMEDIFFERENCE BETWEEN GUILT AND SHAME?SHAME LEADS TO ISOLATION AND DISENGAGEMENT ENEMY WANTS THE LONE RANGER JAMES 5:16NEVER FREE UNTIL WE'RE HONESTWHAT IS KEY TO TRANSPARENCY AND HONESTY?LONELINESS & SUICIDE AT ALL-TIME LEVELSJUNE MENS MENTAL HEALTH AWARENESS MONTHMEN 4X AS MANY SUICIDES AS WOMENHALF AS LIKELY TO SEEK HELPWHY?

With Emma Svennberg, Karolinska Institute, Stockholm -  Sweden, Sabine Ernst, Royal Brompton Hospital, London - UK, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Dominik Linz, Maastricht University Medical Centre (MUMC), Maastricht - The Netherlands. During this podcast, Emma Svennberg, Sabine Ernst, Stefan Simovic and Dominik Linz will tackle EHRA–ESC–HRS scientific statement sets new standards for trustworthy AI in electrophysiology, using a 29-item reporting checklist. EP Europace: State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology

Join host Victoria Carthew as she chats with Sarah Di Lorenzo - resident nutritionist for Channel 7's "Sunrise" and "Weekend Sunrise" - about her brand-new book "The Liver Repair Plan". The liver's ability to heal and regenerate can greatly improve your wellbeing. Clinical nutritionist and bestselling author Sarah Di Lorenzo's four-week plan has helped hundreds of her patients repair their inner health and now she's sharing it with you. "The Liver Repair Plan" offers practical guidance, easy-to-follow meal plans, and more than 50 delicious, nutrient-dense recipes that will support your liver's health and vitality.Purchase your copy of “The Liver Repair Plan” at your local QBD Books store or online today: https://www.qbd.com.au/the-liver-repair-plan/sarah-di-lorenzo-edwina-bartholomew/9781761423895/Follow along with QBD Books here: QBD Books on Facebook: www.facebook.com/qbdbooksQBD Books on Instagram: www.instagram.com/qbdbooksQBD Books on TikTok: www.tiktok.com/@qbdbooksaustralia

Gladys (Sandy) Ramos, M.D. outlines the comprehensive maternal care services at UC San Diego, emphasizing clinical excellence, innovation, and community impact. She highlights programs in diabetes and pregnancy, high-risk obstetrics, postpartum and HIV care, and maternal mental health. Ramos describes cutting-edge capabilities in fetal and placental imaging, including expertise in placenta accreta and genetic counseling. A fetal surgery program is launching soon, expanding access to specialized care and research. The department's patient population closely reflects San Diego County's demographics, which informs both clinical care and research priorities. Ramos also details a collaborative structure with multidisciplinary conferences and welcomes partnerships in research related to maternal, placental, and fetal health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40669]

Gladys (Sandy) Ramos, M.D. outlines the comprehensive maternal care services at UC San Diego, emphasizing clinical excellence, innovation, and community impact. She highlights programs in diabetes and pregnancy, high-risk obstetrics, postpartum and HIV care, and maternal mental health. Ramos describes cutting-edge capabilities in fetal and placental imaging, including expertise in placenta accreta and genetic counseling. A fetal surgery program is launching soon, expanding access to specialized care and research. The department's patient population closely reflects San Diego County's demographics, which informs both clinical care and research priorities. Ramos also details a collaborative structure with multidisciplinary conferences and welcomes partnerships in research related to maternal, placental, and fetal health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40669]

Gladys (Sandy) Ramos, M.D. outlines the comprehensive maternal care services at UC San Diego, emphasizing clinical excellence, innovation, and community impact. She highlights programs in diabetes and pregnancy, high-risk obstetrics, postpartum and HIV care, and maternal mental health. Ramos describes cutting-edge capabilities in fetal and placental imaging, including expertise in placenta accreta and genetic counseling. A fetal surgery program is launching soon, expanding access to specialized care and research. The department's patient population closely reflects San Diego County's demographics, which informs both clinical care and research priorities. Ramos also details a collaborative structure with multidisciplinary conferences and welcomes partnerships in research related to maternal, placental, and fetal health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40669]

Gladys (Sandy) Ramos, M.D. outlines the comprehensive maternal care services at UC San Diego, emphasizing clinical excellence, innovation, and community impact. She highlights programs in diabetes and pregnancy, high-risk obstetrics, postpartum and HIV care, and maternal mental health. Ramos describes cutting-edge capabilities in fetal and placental imaging, including expertise in placenta accreta and genetic counseling. A fetal surgery program is launching soon, expanding access to specialized care and research. The department's patient population closely reflects San Diego County's demographics, which informs both clinical care and research priorities. Ramos also details a collaborative structure with multidisciplinary conferences and welcomes partnerships in research related to maternal, placental, and fetal health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40669]

Gladys (Sandy) Ramos, M.D. outlines the comprehensive maternal care services at UC San Diego, emphasizing clinical excellence, innovation, and community impact. She highlights programs in diabetes and pregnancy, high-risk obstetrics, postpartum and HIV care, and maternal mental health. Ramos describes cutting-edge capabilities in fetal and placental imaging, including expertise in placenta accreta and genetic counseling. A fetal surgery program is launching soon, expanding access to specialized care and research. The department's patient population closely reflects San Diego County's demographics, which informs both clinical care and research priorities. Ramos also details a collaborative structure with multidisciplinary conferences and welcomes partnerships in research related to maternal, placental, and fetal health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40669]

Gladys (Sandy) Ramos, M.D. outlines the comprehensive maternal care services at UC San Diego, emphasizing clinical excellence, innovation, and community impact. She highlights programs in diabetes and pregnancy, high-risk obstetrics, postpartum and HIV care, and maternal mental health. Ramos describes cutting-edge capabilities in fetal and placental imaging, including expertise in placenta accreta and genetic counseling. A fetal surgery program is launching soon, expanding access to specialized care and research. The department's patient population closely reflects San Diego County's demographics, which informs both clinical care and research priorities. Ramos also details a collaborative structure with multidisciplinary conferences and welcomes partnerships in research related to maternal, placental, and fetal health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40669]

In his weekly clinical update, Dr. Griffin with Vincent Racaniello chat about how flies transmit H5N1 to humans via their feet and milk, the recent pertussis oubreak and measles epidemic before Dr. Griffin discusses monoclonal antibody therapy can enrich for RSV variants before deep diving into recent statistics on RSV, influenza and SARS-CoV-2 infections the Wasterwater Scan dashboard, whether or not the NB.1.8.1 should be included in the fall 2025 vaccines, the effectiveness of Sinopharm's COVID-19 vaccine, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, how mast cell activation can enhance long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Flies, ‘milk snatching' among H5N1 transmission contributors in dairy cattle(CIDRAP) H5N1 virus invades the mammary glands of dairy cattle through “mouth-to-teat” transmission (NSR: National Science Review) Mississippi warns of steep increase in pertussis cases (CIDRAP) MSDH Issues Pertussis Alert (Mississippi State Department of Health) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Weekly measles and rubella monitoring (Government of Canada) Measles vaccine recommendations from NYP (jpg) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) ENFLONSIA: novel drug approvals 2025 (FDA) RSV-Network (CDC Respiratory Syncytial virus Infection) Respiratory Syncytial virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis (OFID) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (biRxiV) Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique (CID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Paxlovid (Pfizer) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Mast cell activation symptoms are prevalent in Long-COVID (International Journal of Infectious Diseases) Using the Right Criteria for MCAS (Current Allergy and Asthma Reports) Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndrome (The American Journal of the Medical Sciences) Reaching out to US house representative Letters read on TWiV 1238 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Dr. Jason Crowell discusses clinical considerations when addressing cognitive concerns in patients with Parkinson disease.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000209699  https://directory.libsyn.com/episode/index/id/32642512 

“Next-generation sequencing, or NGS, can be used to help us determine if the patient has specific biomarkers we can identify and use to target for treatment. Certain findings can tell us if a particular treatment might work for that patient, and we can see if there are any genetic variants we might have a biomarker targeted agent to use to treat them with,” ONS member Jackie Peterson, MSN, RN, OCN®, NE-BC, MBA, ambulatory nurse manager at the University of Chicago Medical Center in Illinois, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about prostate cancer and biomarker testing.  This podcast is sponsored by AstraZeneca and is not eligible for NCPD contact hours. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod    Licensed under Creative Commons by Attribution 3.0   Episode Notes This episode is not eligible for NCPD. ONS Podcast™ episodes: Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 180: Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care ONS Voice articles: An Oncology Nurse's Guide to Cascade Testing Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Disorders Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Germline and Somatic Variants: What Is the Difference? Help Patients Understand Genomic Variants of Unknown Significance Prostate Cancer Clinical Trials Don't Reflect Racial Diversity—And It's Getting Worse Over Time Prostate Cancer Disparities Disappear With Equal Access to Care Prostate Cancer Prevention, Screening, Treatment, and Survivorship Recommendations The Case of the Genomics-Guided Care for Prostate Cancer ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses ONS course: Genomic Foundations for Precision Oncology Clinical Journal of Oncology Nursing articles: Metastatic Prostate Cancer: An Update on Treatments and a Review of Patient Symptom Management Prostate Cancer: How Nurse Practicioners Can Aid in Disease Diagnosis and Management Oncology Nursing Forum article: Identification of Symptom Profiles in Prostate Cancer Survivors Other ONS Resources: Biomarker Database (refine by prostate cancer or specific biomarkers) Clinical tool/case study: Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Genomics and Precision Oncology Learning Library Huddle Card: Genomic Biomarkers Infographic: Talking to Your Patient About a Germline Variant of Uncertain Significance (VUS) American Cancer Society - Genetic Testing and Counseling for Prostate Cancer Risk American Cancer Society - Prostate Cancer Clinicaltrials.gov National Cancer Institute - Prostate Cancer National Comprehensive Cancer Network ZERO Prostate Cancer To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode “Some of the risk factors for developing prostate cancer include age, race, family history, and certain genetic changes or variants. Prostate cancer has some hereditary components, but most prostate cancer occurs in men without any significant family history of it.” TS 1:31 “Key biomarkers include PSA and prostate cancer gene 3, which is PCA3, and prostate-specific membrane antigen, or PSMA. Other biomarkers that are important for us to test include BRCA1, BRCA2, and Lynch syndrome–associated genes, which are MLH1, MSH2, MSH6, PMS2, and EPCAM. Biomarkers can be collected via your blood, urine, saliva, or tissue samples, so these are different ways that we can test and look for biomarkers in our patients.” TS 3:24 “It does matter how advanced the disease is. Usually, for our castrate-sensitive patients, they respond better to androgen deprivation therapy because that really is slowing down the growth of the cancer by reducing the available testosterone that the cancer needs to grow. Whereas our patients that are more advanced and have castrate-resistant prostate cancer, that cancer will continue to grow despite having the lowered testosterone levels, so they might need additional layers of treatment to really get their cancer under control.” TS 7:50 “When I talk to [patients] about biomarker testing, I tell them it's another tool in our toolbox that we can use to help us determine if they might benefit from other therapy options now or in the future. I tell them that sometimes we'll get a report back with a variant of unknown significance, and basically that means that we don't really know whether or not this has an impact on their health or risk factors for the disease. That can sometimes be a little bit of a concern for these patients, so we just have to reassure them that we're continually doing research around biomarker testing. The science is always advancing, so if there's something that [researchers] find in the future, we'll make them aware of that.” TS 9:08 “One of the biggest topics I think about is the inequity that exists in biomarker testing and research, especially surrounding the African American population. When these tests were developed, that population really wasn't studied as much, so there's not a lot of good data yet to make a decision or impact on those patients and that population.” TS: 12:30

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Donanemab's New Dosing Regimen: Lowering ARIA Risk in Alzheimer's Care" John Sims, MD, head of medical development for donanemab at Eli Lilly and Company, joins NeurologyLive to discuss the recently updated label for donanemab (Kisulna), an anti-amyloid Alzheimer disease (AD) therapy. Sims breaks down the key safety data from the TRAILBLAZER-ALZ-6 study (NCT05738486) that led to a newly approved titration-based dosing regimen aimed at minimizing ARIA risk. He outlines considerations for clinicians treating patients with early-stage AD, including genotype-based stratification, ARIA severity patterns, and implications for prescribing and patient counseling. Furthermore, Sims also shares takeaways about donanemab's clinical impact and how the results may shape the future of anti-amyloid therapy development and AD care. Looking for more dementia and Alzheimer disease discussion? Check out the NeurologyLive® Dementia and Alzheimer disease clinical focus page. Episode Breakdown: 1:00 – Overview of the new donanemab dosing regimen and its goal to reduce ARIA risk 2:30 – Rationale behind the four different dosing strategies tested in Trailblazer-ALZ-6 6:00 – What clinicians should know about patient risk and genotype testing 8:00 – Neurology News Minute 10:10 – Clinical implications of the updated label, including risk-benefit conversations 13:45 – Surprising results from the trial, particularly for APOE4 homozygous patients The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Orexin-Targeting Agent TAK-861 Meets All End Points in Phase 3 FirstLight and RadiantLight Studies FDA Shuts Down Sarepta's Distribution of Gene Therapy Elevidys Following Patient Deaths AD109 Meets End Points in Phase 3 LunAIRo Trial, Eyeing FDA Submission for Obstructive Sleep Apnea Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

This week, Dr. Slaven Bajic we have another presentation from our Medicine in the Mediterreanean conference from January 2025. In this lecture, Slaven discusses the importance of ultrasound in pre-hospital settings, its advantages, limitations, and a case study demonstrating its application in trauma care. The discussion emphasises the need for clinical judgment alongside ultrasound findings and the growing role of ultrasound in modern emergency medicine.TakeawaysFocused ultrasound is revolutionising emergency medicine.The FAST protocol is essential for trauma assessment.Ultrasound can be more effective than traditional methods.Rapid identification of unstable patients is critical.FAST exams must be repeated to ensure accuracy.Ultrasound is a non-invasive and portable technology suitable for field use.Clinical judgment is crucial when interpreting FAST results.Ultrasound can facilitate prompt decision-making in emergency situations.Training and practice are vital for effective ultrasound use.Ultrasound technology is becoming indispensable in emergency settings.Chapters00:00 Introduction to Focused Ultrasound in Emergency Medicine02:27 Understanding the FAST Protocol04:40 Advantages of FAST in Pre-Hospital Settings07:28 Limitations and Challenges of FAST09:49 Case Study: Application of FAST in Trauma17:32 Conclusion and Future of Ultrasound in Emergency Medicine

In this episode, Stacey Richter discusses 'Three Surprising Ways Carriers Make Lots of Money' with Preston Alexander. The episode highlights how carriers leverage financial strategies—like using premium dollars as float, intracompany eliminations, and upcoding in Medicare Advantage—to enhance their profits.  The discussion emphasizes the importance for plan sponsors and policymakers to understand these tactics to better manage healthcare costs. Alexander advises collaborating with unbiased consultants who are experts in health plan design to navigate these complex financial dynamics effectively. === LINKS ===

Dr. Jason Crowell talks with Dr. Daniel Weintraub about clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease.  Read the related article in Neurology®.  Listen to the related podcast episode with Dr. Jeff Ratliff.  Disclosures can be found at Neurology.org. 

Janet returns to Paranoi Radio to expose the hidden world of red light therapy—this time diving deeper into ancient healing tech, secret medical procedures, and the frequencies they don't want you absorbing. From underground clinics to forgotten light rituals, this episode uncovers the power of light to heal, control, and awaken.CONTACT DEPLORABLE JANET VISIT DEPLORABLE NATION// Paranoi Radio is on YouTube

Matt and Allie present this month's clinical corner article that basically supports the whole theme of our podcast! Matt introduces the research report that tested the pathway of using direct access in visiting a PT first in comparison to the physician pathway alone. The study covered 66 children/adolescents presenting with muscle pain and split them into groups to compare the results. The patients who used their direct access showed higher rates of retention and compliance in their care! Read the article here: https://www.jospt.org/doi/10.2519/jospt.2025.13321Did you know that you don't need a doctor's prescription to receive physical therapy? The laws of Direct Access allow you to receive physical therapy without a referral and still use your insurance benefits! Learn more on how Direct Access can help YOU! Our website: https://www.oxfordphysicaltherapy.com/

Alyssa Parten, PhD, CSCS, is a Clinical Assistant Professor of Kinesiology at The University of Alabama. Her research centers on resistance training and female physiology, with a focus on strategies to enhance female exercise performance and how resistance training may impact female long-term health. Dr. Alyssa Parten shares her expertise on female physiology and resistance training, challenging conventional wisdom about menstrual cycle-based training while advocating for personalized, auto-regulated approaches instead.• Clinical assistant professor of kinesiology researching resistance training in female physiology• Competitive powerlifter with a 292.5 lb squat, 187.5 lb bench press, and 375 lb deadlift at 138 lbs bodyweight• Research found no significant metabolic differences between follicular and luteal phases• Auto-regulation through RPE is more effective than strict cycle-based training programs• Normal menstrual cycle length ranges from 24-39 days, with significant individual variation• Traditional powerlifting and bodybuilding training are both effective for female physiology• Leading FEMPOWER research team studying women-specific training adaptations• Current projects examine post-activation performance enhancement protocols for women• Future research will explore resistance training benefits during perimenopause and menopause

On this week's Inside Startup Investing, Dr. Nicole Paulk—founder & CEO of Siren Biotechnology—details her AAV gene-therapy “FedEx truck” that can deliver anti-tumor cytokines directly to brain cancers. Early animal data show 86 % complete responses; the FDA has signaled a fast-track path for Siren's first-in-human trial set for 2026. With analog comps like Keytruda earning $30 B a year, Siren's upside—and impact—could be enormous.Highlights include...Why viruses? AAV viruses don't cause disease in humans yet efficiently deliver genetic payloads; Siren re-engineers them to express anti-tumor cytokines.Twin “firsts.” Siren pursues the first AAV-based cancer therapy and the first single virus platform scalable to hundreds of indications.Animal data. >500 mouse models show 86 % complete responses; large-animal pig study indicates strong safety with real-world neurosurgical delivery.Clinical plan. Combined Phase 1/2 trial in adults with recurrent high-grade gliomas targeted for 2026 with potential for rare-disease (orphan) fast-track.Market context. Current SOC for brain tumors is largely ineffective; analogous immunotherapies like Keytruda generate ~$30 B annually.

The Healing Power of Honesty: Trauma, Truth, and Relationship Repair Episode Summary: In this episode of The Human Intimacy Podcast, Dr. Kevin Skinner and MaryAnn Michaelis take a deep dive into the role of honesty in trauma recovery and relational healing. The conversation begins with MaryAnn recounting a personal traumatic experience of being held at gunpoint and how it changed her sense of safety and interaction with the world. Together, they explore how honesty with ourselves and others helps reprocess trauma, fosters emotional congruence, and sets the foundation for mental and relational well-being. The discussion expands to topics such as the danger of minimizing experiences, the impact of secrets in relationships, the importance of safe disclosure, and the difference between radical honesty and emotionally responsible honesty. They address the nuances of when, how, and why to tell the truth—whether in moments of betrayal or in everyday interactions. Drawing from clinical experience and research, the hosts emphasize that honesty isn't just about facts—it's a healing process that reconnects us to ourselves and to those we love. Key Themes Covered: Trauma and the importance of finding safety after harm Emotional congruence and the danger of self-deception How dishonesty (even subtle) erodes trust and mental health The role of disclosure in healing betrayal trauma How to be honest without overwhelming or harming others The neuroscience of honesty and emotional regulation Rupture and repair as foundations for resilient relationships Balancing rigorous honesty with emotional responsibility Resources Mentioned: Quote by David Viscott: “If you lived honestly, your life would heal itself.” Book: Facing Codependence by Pia Mellody Explores how early life experiences shape adult behavior and emotional health. Book: Dopamine Nation by Dr. Anna Lembke Highlights how honesty activates the prefrontal cortex, aiding in emotional regulation and reducing compulsive behavior. 12-Step Traditions: Emphasis on "rigorous honesty" and the adage “We are as sick as our secrets.” Peggy Vaughan's Research on Disclosure: Found that 86% of couples who openly talk about the details of betrayal stay together, compared to 55% who do not. Clinical concept: Rupture and Repair Healthy relationships aren't free of conflict; they thrive through honest repair. Therapeutic concept: Congruence (from Carl Rogers) Healing begins when our internal experience aligns with our external expression. Story from Patrick Carnes: A family laughing about a traumatic event illustrates the confusion caused by cognitive dissonance and emotional invalidation. Call to Action: Take a moment to reflect: Where might you be avoiding honesty with yourself or someone close to you? Are there unspoken truths or emotions that need a safe space to be acknowledged? Consider journaling or speaking with a trusted person or therapist about your experience. Being honest doesn't mean being harsh—it means being real. And in that reality, healing begins.

Nursing clinical judgment is a concept that resonates with nurse educators. This topic coincides with the National Council of State Board of Nursing clinical judgment model, the American Association of Colleges of Nursing Essentials, state boards of nursing, and employer and public importance. As such, it is vital to incorporate clinical judgment into nursing education. This podcast with Dr. Sara Lewandowski presents an engaging and active learning experience to promote effective assessment and critical thinking skills in students. You can read more about this strategy in her article.

Chris O'Connor opens up about his journey from academic burnout to building Incidental, sharing hard-won insights about workaholic tendencies, clinical mastery, and the realities of running a dental supply business. This episode explores the darker side of perfectionism, the complexity of clinical decision-making, and how childhood experiences shape professional drive. O'Connor discusses everything from innovative matrixing techniques to the emotional toll of litigation, offering a brutally honest perspective on modern dentistry practice.In This Episode00:01:00 - Newcastle move 00:01:45 - PhD research 00:03:00 - Clinical trials 00:11:15 - Career transition 00:15:10 - Workaholic tendencies 00:16:45 - Family background 00:21:25 - Workflow obsession 00:24:30 - Russian sanctions 00:26:30 - Founding Incidental 00:31:05 - Clinical weaknesses 00:36:25 - Patient experience 00:42:35 - Customer relationships 00:47:05 - Marketing approach 00:54:10 - Teaching philosophy 00:57:10 - Product development 01:02:30 - Regulatory challenges 01:04:20 - Parenting struggles 01:07:15 - Rubber dam techniques 01:12:35 - Matrix systems 01:19:50 - Blackbox thinking 01:25:25 - Complex cases 01:32:35 - Pricing structure 01:42:35 - Best lecture 01:46:50 - Future aspirations 01:48:15 - Fantasy dinner party 01:50:25 - Last days and legacyAbout Chris O'ConnorChris O'Connor is a dentist, dental supplier, and product developer based in Newcastle. He co-founded Incidental, a dental supply company known for innovative matrixing solutions and educational courses. A former clinical academic, Chris spent eight years at Newcastle Dental Hospital conducting research and teaching before transitioning to practice and business.

Join us in this episode of Skin Anarchy as Dr. Ekta Yadav sits down with Ohad Bendror, founder and CEO of NanoSpun Technologies, to explore one of the most radical shifts in skincare: living, on-demand microbiome delivery. While most brands tout probiotics with shelf-stable claims, NanoSpun is building something entirely different—a biological platform that brings real, live cells directly to your skin.Ohad reveals how NanoSpun's technology works like a biotech engine—activating 100 billion+ live bacteria only when it hits your skin, preserving potency like “freshly squeezed juice.” It's not just delivery—it's a living factory in a face mask.This isn't about trends—it's about disrupting four major layers of the skincare model: real live cells, shelf-stable dormancy, on-demand activation, and functional delivery systems. The result? Postbiotics synthesized in real time, tailored to skin concerns like acne, aging, or sensitivity.NanoSpun isn't just a brand—it's a platform. From white-labeled partnerships to its in-house line Biotica 1905, it's redefining what skincare can do. Clinical results show improvements in hydration, redness, and fine lines in just weeks.If you've ever wondered what comes after serums and synthetics—this is it. Tune in to hear how NanoSpun is building the biological infrastructure of beauty and why the future of skincare is very much alive.CHAPTERS:(0:00) Introduction to NanoSpun and Ohad Bendror(1:03) The Birth of NanoSpun and Its Core Technology(2:30) Explaining Postbiotics and Their Relevance in Skincare(4:46) The Four-Layer Disruption: A New Approach to Skin Microbiome(7:51) Solving the Shelf Life Problem and Maintaining Bioavailability(9:57) The Role of Live Cell Technology in Skincare(14:03) Scaling and Customization: How NanoSpun Works for Different Skin Needs(19:19) The Future of Personalized Skincare with NanoSpun and AI(27:06) The Long-Term Roadmap and Potential of NanoSpun TechnologyTo learn more about NanoSpun, visit their website and social media.Learn more about Function Health and join using our link. The first 1000 get a $100 credit toward their membership. Visit www.functionhealth.com/SKINANARCHY or use gift code SKINANARCHY at sign-up to own your health.Please fill out this survey to give us feedback on the show!Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf! Hosted on Acast. See acast.com/privacy for more information.

In this episode, Kevin and Zach return from a hiatus and catch up on their summer adventures before introducing a special guest: Kevin's hygienist, Maryann McFarland. Maryann shares her journey through a 32-year career in hygiene, from a frustrating first job in a "prophy mill" to finding her work home in Kevin's practice. She discusses how embracing new challenges like sleep apnea treatment, clear aligner therapy, and administering local anesthesia has reinvigorated her passion for dentistry and transformed her job satisfaction. Key Takeaways Find Your "Work Home": A positive and supportive work environment is crucial for long-term career satisfaction. Maryanne's story shows the stark contrast between a high-turnover practice and one that invests in its team. Trust Empowers Your Team: Practice owners who trust their team members with new responsibilities and encourage them to develop their skills can unlock a higher level of engagement and satisfaction. As Maryanne says, Kevin "finds what we're good at and he lets us run with it." Hygiene is More Than Cleaning Teeth: Expanding a hygienist's role beyond traditional prophies to include comprehensive care like sleep apnea, orthodontics, and implants can combat burnout and foster significant professional growth, even for a 30+ year veteran. Embrace Lifelong Learning: Being open to learning new skills, like when Maryanne took on local anesthesia after 30 years without it, can be challenging but ultimately become one of the most rewarding parts of the job. Join the Very Dental Facebook group using the password "Timmerman," Hornbrook" or "McWethy," "Papa Randy," "Lipscomb" or "Gary!" The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! -- Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code “VERYDENTAL10” you'll get another 10% off your order! Go save yourself some money and support the show all at the same time! -- The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! -- Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! -- CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

When it comes to babies, there is one true common denominator for new parents — poop. While it's one of the first things parents can fixate over, pediatricians know what's in the diaper can say a lot about what's going on inside that tiny body. From understanding different stool colors and consistency, to the difference in diaper contents between breast-fed and formula-fed babies, there's a lot to learn about baby poop. This episode was recorded on the exhibit floor at the 2025 Pediatric Academic Societies Conference in Honolulu, Hawaii. Joining us for this episode is Adrienne Hoyt-Austin, DO, a pediatrician and lactation consultant with UC Davis Health. She specializes in general pediatrics and breastfeeding medicine and is also an Assistant Professor of Clinical Pediatrics. Some highlights from this episode include:  What baby poop can reveal about their health How to distinguish between normal variations in stool and potential concerns   Common colors and consistencies  Biggest red flags to look for in baby poop  Charting Pediatrics is in the running for a People's Choice Podcast Award, and we need your help to get nominated! Starting July 1, you can head to www.podcastawards.com and nominate us for the “science and medicine” category, as well as the “people's choice” category. Listeners like you are the reason we have become one of the top pediatric podcasts for providers around the world. Your nomination could make all the difference in us receiving this recognition! Nominate us by July 31 and help Children's Hospital Colorado lead the way in pediatric podcasting. Thank you for your support!   For more information on Children's Colorado, visit: childrenscolorado.org. 

In this episode of Medsider Radio, we sat down with Maulik Nanavaty, CEO of Anumana. Anumana, an AI-driven health technology company focused on cardiovascular care, is taking a pragmatic approach to scaling AI in medicine.Maulik is a seasoned healthcare executive with over 30 years of global experience in the medical device industry. He spent 18 years at Boston Scientific, where he led its $1B+ Neuromodulation division and served as President of Boston Scientific Japan. Prior to that, he held leadership positions at Baxter. Known for driving innovation in implantable and artificial intelligence (AI)-powered technologies, Maulik also serves on the board of Rani Therapeutics.In this interview, Maulik shares why building a strong risk-benefit case and designing around real-world clinician needs are key to adoption. With data from over 20 million patients and a focus on transparency, Anumana is reshaping how AI reaches the point of care.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Maulik Nanavaty.

In this episode, Priya Streram from Singapore joins Ané Lloyd for a fascinating conversation about applied anatomy. They are both very passionate about this topic. They dive into how anatomical knowledge supports clinical reasoning, helps identify compensatory patterns, and enhances assessment beyond the obvious pathology. From myofascial trigger points to real-world application, this episode is packed with valuable insights.  Learn more about Priya Streram: https://arkvetrehab.getlearnworlds.com/about Learn more about the Canine Muscle Anatomy, Simplified eBook: https://onlinepethealth.com/anatomybook/ Learn more about Priya Streram's course: https://onlinepethealth.com/anatomycourse/  Find out more about the Vet Rehab Summit: https://vetrehabsummit.com/ Learn more about Paw Prosper's special offer: https://pawprosper.com/OPH Learn more about Paw Prosper: https://pawprosper.com/ To learn about Onlinepethealth, watch a free webinar, or join any of our Facebook groups, click here: https://onlinepethealth.com/podcast

In this episode of the RWS Clinician's Corner, Margaret Floyd Barry sits down with Kim Vopni, widely known as the “vagina coach.” Kim is a certified fitness professional and menopause support practitioner with over two decades of experience educating women—and the clinicians who serve them—about the vital but often overlooked world of pelvic health. In this episode, we get into the nuts and bolts of pelvic floor physiology, what every clinician should be screening for, and why pelvic health is central not just to continence but to bone health, athletic performance, and overall quality of life.   In this interview, we discuss:      -The obvious and less-obvious symptoms of pelvic floor dysfunction    -Clinical assessment and clues for pelvic floor dysfunction    -Pelvic floor health and broader health issues (e.g., low back pain and bone health)    -Common misconceptions about pelvic floor health and interventions (e.g. pelvic floor PT)    -Pelvic floor issues across life stages (from younger women into perimenopause & menopause)      -Management strategies and self-care recommendations The Clinician's Corner is brought to you by Restorative Wellness Solutions.  Follow us: https://www.instagram.com/restorativewellnesssolutions/    Join us for a FREE 3-Part Fertility Masterclass Series: Precision Nutrition for Fertility Grab your spot now!    Connect with Kim Vopni: Website: https://www.vaginacoach.com/ Facebook: https://www.facebook.com/VagCoach Instagram: https://www.instagram.com/vaginacoach/?hl=en YouTube: https://www.youtube.com/@vaginacoach/videos   For a FREE copy of Kim's book, The Inside Story - click here. For The Buff Muff Method/App, click here.    For pelvic floor physical therapy, check out these directories: American Physical Therapy AssociationPelvic Global    Timestamps: 00:00 "Pelvic Health Insights with Kim" 07:22 "Pelvic Floor's Role in Stability" 14:10 "Pelvic Floor and Constipation Cycle" 17:00 Pelvic Floor Muscle Adaptations 22:57 Finding a Pelvic Floor Therapist 30:01 Fertility Masterclass for Practitioners 33:54 Runner's Pelvic Floor Challenges 40:23 Bladder Habits and Sleep Disruption 44:19 "Transition to Minimal Footwear" 51:41 Collagen's Role in Pelvic Health 56:58 Enhancing Pelvic Floor Relaxation Techniques 57:56 Improving Posture for Pelvic Health 01:07:59 Pelvic Health Through Life Stages 01:09:38 "Clinician's Corner: Join & Share" Speaker bio: Kim Vopni is a certified fitness professional and menopause support practitioner known as The Vagina Coach. She became passionate about spreading information on pelvic health after the birth of her first child over 20 years ago. Kim is a sought-after speaker, a women's health educator, and the author of 3 books. She began her work with the prenatal and postpartum population where she founded her own business and co-founded a 2nd company called Bellies, Inc. She now works primarily with women in the perimenopause and post menopause phases of life. Doctors and Physical Therapists are always referring their clients to her Buff Muff Method as the go-to pelvic health resource that allows women from around the world find support through workouts, challenges, and group coaching. Kim also certifies other fitness and movement professionals to work with women with core and pelvic floor challenges through her Buff Muff Method Practitioner Certification. You can find her online through her website, social media, and her podcast Between Two Lips. Keywords: pelvic floor health, incontinence, pelvic organ prolapse, perimenopause, menopause, pelvic floor physical therapy, Buff Muff Method, pelvic floor exercises, Kegels, pelvic health assessment, constipation, low back pain, posture, hydration, vaginal estrogen, pelvic floor dysfunction, pelvic pain, sexual health, pelvic floor relaxation, core strength, women's health, bone health, stress and anxiety, vaginacoach, pelvic health screening, pelvic floor tightness, bladder health, postpartum recovery, pelvic health practitioners, movement therapy Disclaimer: The views expressed in the RWS Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of Restorative Wellness Solutions, LLC. Restorative Wellness Solutions, LLC does not specifically endorse or approve of any of the information or opinions expressed in the RWS Clinician's Corner series. The information and opinions expressed in the RWS Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. Restorative Wellness Solutions, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the RWS Clinician's Corner series. By viewing or listening to this information, you agree to hold Restorative Wellness Solutions, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

A recent Review discusses the epidemiology, risk factors, diagnosis, and treatment of ovarian cancer. William Cliby, MD, and John Weroha, MD, PhD, both from the Mayo Clinic in Rochester, Minnesota, discuss this and more with JAMA Associate Editor Margaret Wheeler, MD. Related Content: Ovarian Cancer Endometriosis Typology and Ovarian Cancer Risk Screening for Ovarian Cancer ----------------------------------- JAMA Editors' Summary

Clinical Breast Exam – What Your Doctor Does (and Doesn't)In this episode, Dr. Barbara 'Menopause' Taylor breaks down what a clinical breast exam entails—and how it compares to the self breast exam you do at home. Drawing from years of experience, she reveals why you may actually be better at detecting changes in your own breasts than your doctor. From timing and technique to familiarity and focus, this episode highlights why both types of breast exams matter—but also why your hands may be your most powerful diagnostic tool.Visual learner? Find the corresponding Menopause Taylor YouTube video here. Click here for more about one-on-one consultations and Dr. Taylor's menopause resources. Looking for a roadmap to successful menopause management? Dr. Taylor's new ebook, How to Win at Menopause: A Guide to Raising - and Winning- Your Game Your Way, will bring confidence and clarity to your menopause journey. Avoid common pitfalls and learn to navigate a healthcare system that focuses more on disease than prevention, where many professionals lack the relevant education and/or the motivation to help you.

What happens when the journey into parenthood collides with mental health challenges? This episode pulls back the curtain on a critical yet often overlooked aspect of becoming a parent - perinatal mental health - and discusses The Menninger Clinic's innovative "hospital without walls" approach to supporting families.  Clinical social workers Emily Pyle, LPC-S, and Michael Riley, LCSW-S, from Menninger 360 join us to explore their wraparound care model that meets parents exactly where they are - in their homes and communities. They reveal a stark reality --- that perinatal mood and anxiety disorders are the leading medical complication in childbearing and the leading cause of maternal death in the United States, affecting one in three pregnancy-related deaths.  The conversation explores how mental health challenges manifest differently between birthing parents and their partners, with fascinating insights into the biological and psychosocial factors involved. They reveal that up to 10% of new fathers experience clinical depression or anxiety, often showing symptoms through distancing behaviors, substance use, and irritability. Also sharing that  fathers undergo documented hormonal shifts including decreased testosterone and increased cortisol.  Moving to a multigenerational perspective, the discussion examines how untreated perinatal mental health issues can impact child development through disrupted attachment and the modeling of coping mechanisms. Our experts share crucial warning signs for clinicians and loved ones to watch for, while emphasizing that effective, evidence-based treatments exist, emphasizing that the challenge lies in making them accessible.  Whether you're a mental health professional, an expectant parent, or someone supporting a growing family, this episode offers vital insights into creating supportive environments during one of life's most transformative journeys. Listen and join the conversation about how we can better support the mental health of parents and families.Follow The Menninger Clinic on Twitter, Facebook, Instagram and LinkedIn to stay up to date on new Mind Dive episodes. To submit a topic for discussion, email podcast@menninger.edu. If you are a new or regular listener, please leave us a review on your favorite listening platform! Visit The Menninger Clinic website to learn more about The Menninger Clinic's research and leadership role in mental health.

Send us a textPerinatal Urinary Tract Dilation: Recommendations on Pre-/Postnatal Imaging, Prophylactic Antibiotics, and Follow-up: Clinical Report.Anthony Herndon CD, Otero HJ, Hains D, Sweeney RM, Lockwood GM; Section on Urology; Section on Nephrology; Section on Radiology; Section on Hospital Medicine.Pediatrics. 2025 Jul 1;156(1):e2025071814. doi: 10.1542/peds.2025-071814.PMID: 40518141 Review.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!